ArticleScientific reports2018

Suppression of GPR56 expression by pyrrole-imidazole polyamide represents a novel therapeutic drug for AML with high EVI1 expression.

Hasi Rani Saha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.